Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 5:45 AM ET

Life Sciences Tools and Services

Company Overview of Agilux Laboratories, Inc.

Company Overview

Agilux Laboratories, Inc., a contract research organization, offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic (DMPK) Services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays (biomarkers) services. Agilux Laboratories was founded in 2007 and is based in Worcester, Massachusetts.

One Innovation Drive

Three Biotech

Worcester, MA 01605

United States

Founded in 2007





Key Executives for Agilux Laboratories, Inc.

Co-Founder, Chief Executive Officer and President
Co-Founder and Chairman
Age: 49
Co-Founder and Vice President of Sales & Marketing
Senior Director of Operations and IT
Head of GLP Bioanalysis - Pharmaceutical Development Services
Compensation as of Fiscal Year 2015.

Agilux Laboratories, Inc. Key Developments

Agilux Laboratories, Inc. Adds MDCK/MDCK-MDR1 Assays to its Suite of ADMET in Vitro Assay Services

Agilux Laboratories, Inc. announced that it is now offering MDCK/MDCK-MDR1 assays, in addition to the existing Caco-2 assays, for assessing the membrane permeability properties of early drug discovery compounds. These permeability assays are part of their extensive suite of ADMET in vitro assay services. Caco-2 assays are used to predict intestinal absorption and also potential efflux by transporters, including P-glycoprotein (Pgp). Likewise, MDCK cells transfected with human MDR1 (Pgp) are useful for assessing candidate compounds for potential as a Pgp substrate or inhibitor, as well as blood-brain-barrier penetration. These assays have been extensively evaluated and qualified to assure their optimum performance and reliability.

Agilux Laboratories, Inc. Appoints Richard M. LeLacheur as Head of GLP Bioanalysis for Bioanalytical Operations

Agilux Laboratories, Inc. announced that it has appointed Richard M. LeLacheur, Ph.D. to Head of GLP Bioanalysis for its pharmaceutical development services. Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.

Similar Private Companies By Industry

Company Name Region
Cyntellect Inc. United States
Lighthouse Instruments LLC United States
The F. Dohmen Co. United States
BioScale, Inc. United States
Xcelience, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Agilux Laboratories, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at